Header Logo

Connection

SALIM VIRANI to Heart Failure

Back to Details
This is a "connection" page, showing publications SALIM VIRANI has written about Heart Failure.
SALIM VIRANI
Connection Strength
5.322
Heart Failure
  1. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
    View in: PubMed
    Score: 0.348
  2. Demographic and Regional Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999 to 2019. Circ Heart Fail. 2022 09; 15(9):e009292.
    View in: PubMed
    Score: 0.332
  3. SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently? Curr Atheroscler Rep. 2022 08; 24(8):627-634.
    View in: PubMed
    Score: 0.326
  4. Highlights from Studies Presented at the American Heart Association Scientific Session 2020: Navigating New Roads in Prevention. Curr Atheroscler Rep. 2021 01 03; 23(1):4.
    View in: PubMed
    Score: 0.296
  5. Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review. Am J Emerg Med. 2021 Aug; 46:204-211.
    View in: PubMed
    Score: 0.286
  6. Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session. Curr Atheroscler Rep. 2020 06 18; 22(8):32.
    View in: PubMed
    Score: 0.285
  7. Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials. Curr Atheroscler Rep. 2019 01 10; 21(1):1.
    View in: PubMed
    Score: 0.258
  8. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol. 2016 Mar; 39(3):145-9.
    View in: PubMed
    Score: 0.211
  9. Ongoing and future clinical trials of device therapies for patients with heart failure. Curr Probl Cardiol. 2024 Nov; 49(11):102805.
    View in: PubMed
    Score: 0.095
  10. Trajectory of C-Reactive Protein and Incident Heart Failure in Black Adults: The Jackson Heart Study. Circ Heart Fail. 2024 Aug; 17(8):e011199.
    View in: PubMed
    Score: 0.095
  11. Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure. Am J Cardiovasc Drugs. 2024 Jul; 24(4):481-504.
    View in: PubMed
    Score: 0.094
  12. Association of High-Density Lipoprotein Parameters and Risk of Heart?Failure: A Multicohort Analysis. JACC Heart Fail. 2024 Jul; 12(7):1242-1253.
    View in: PubMed
    Score: 0.093
  13. What is the additive value of nutritional deficiency to VA-FI in the risk assessment for heart failure patients? J Nutr Health Aging. 2024 Jul; 28(7):100253.
    View in: PubMed
    Score: 0.093
  14. Association of cardiometabolic and vascular atherosclerosis phenotypes on non-contrast chest CT with incident heart failure in patients with severe hypercholesterolemia. J Clin Lipidol. 2024 May-Jun; 18(3):e403-e412.
    View in: PubMed
    Score: 0.092
  15. Trends in sleep apnea and heart failure related mortality in the United States from 1999 to 2019. Curr Probl Cardiol. 2024 Feb; 49(2):102342.
    View in: PubMed
    Score: 0.091
  16. Development and Validation of the American Heart Association's PREVENT Equations. Circulation. 2024 02 06; 149(6):430-449.
    View in: PubMed
    Score: 0.090
  17. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023 12 12; 148(24):1982-2004.
    View in: PubMed
    Score: 0.090
  18. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2023 11 09; 30(16):1731-1740.
    View in: PubMed
    Score: 0.090
  19. Association of Hospital Procedural Volume With Outcomes of Left Ventricular Assist Device Placement. J Card Fail. 2023 11; 29(11):1531-1538.
    View in: PubMed
    Score: 0.088
  20. Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018). Am J Cardiol. 2023 09 01; 202:41-49.
    View in: PubMed
    Score: 0.088
  21. Celiac Disease and the Risk of Cardiovascular Diseases. Int J Mol Sci. 2023 Jun 09; 24(12).
    View in: PubMed
    Score: 0.087
  22. Predictors of Non-Obstructive Coronary Artery Disease in Patients Undergoing Elective Coronary Angiography. Glob Heart. 2023; 18(1):26.
    View in: PubMed
    Score: 0.087
  23. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. 2023 03 01; 8(3):222-230.
    View in: PubMed
    Score: 0.086
  24. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. JACC Heart Fail. 2023 04; 11(4):440-450.
    View in: PubMed
    Score: 0.085
  25. Family income and cardiovascular disease risk in American adults. Sci Rep. 2023 01 06; 13(1):279.
    View in: PubMed
    Score: 0.085
  26. Developing a Parsimonious Frailty Index for Older, Multimorbid Adults With Heart Failure Using Machine Learning. Am J Cardiol. 2023 03 01; 190:75-81.
    View in: PubMed
    Score: 0.085
  27. Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure. Methodist Debakey Cardiovasc J. 2022; 18(5):40-53.
    View in: PubMed
    Score: 0.084
  28. Association of dementia with in-hospital outcomes in primary heart failure and acute myocardial infarction hospitalizations. Prog Cardiovasc Dis. 2022 Jul-Aug; 73:24-31.
    View in: PubMed
    Score: 0.082
  29. Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018. Circ Heart Fail. 2022 05; 15(5):e008943.
    View in: PubMed
    Score: 0.080
  30. A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:94-96.
    View in: PubMed
    Score: 0.078
  31. Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions Towards Healthcare Equity. Curr Atheroscler Rep. 2021 07 26; 23(9):55.
    View in: PubMed
    Score: 0.077
  32. Social media and predictive analysis regarding dietary approaches to stop hypertension. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:88-90.
    View in: PubMed
    Score: 0.077
  33. Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Rev Med Virol. 2021 05; 31(3):e2172.
    View in: PubMed
    Score: 0.072
  34. Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes (Lond). 2020 07; 44(7):1561-1567.
    View in: PubMed
    Score: 0.071
  35. Incorporating Guideline Adherence and Practice Implementation Issues into the Design of Decision Support for Beta-Blocker Titration for Heart Failure. Appl Clin Inform. 2018 04; 9(2):478-489.
    View in: PubMed
    Score: 0.062
  36. Life's Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Jun 27; 6(6).
    View in: PubMed
    Score: 0.058
  37. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study. Atherosclerosis. 2017 07; 262:131-137.
    View in: PubMed
    Score: 0.057
  38. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
    View in: PubMed
    Score: 0.056
  39. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63.
    View in: PubMed
    Score: 0.056
  40. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Eur J Prev Cardiol. 2017 04; 24(6):628-638.
    View in: PubMed
    Score: 0.056
  41. Economic Impact of Moderate-Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel?Survey. J Am Heart Assoc. 2016 09 07; 5(9).
    View in: PubMed
    Score: 0.055
  42. Gender disparities in cardiovascular care access and delivery in India: Insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). Int J Cardiol. 2016 Jul 15; 215:248-51.
    View in: PubMed
    Score: 0.053
  43. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9.
    View in: PubMed
    Score: 0.049
  44. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 01; 113(11):1834-8.
    View in: PubMed
    Score: 0.046
  45. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem. 2013 Dec; 59(12):1802-10.
    View in: PubMed
    Score: 0.045
  46. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Circ Heart Fail. 2013 Sep 01; 6(5):936-43.
    View in: PubMed
    Score: 0.044
  47. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011 Apr 05; 123(13):1367-76.
    View in: PubMed
    Score: 0.037
  48. Bayesian Model Projecting Cardiovascular Disease Related Mortality Trends in the United States. J Am Heart Assoc. 2024 Nov 05; 13(21):e035922.
    View in: PubMed
    Score: 0.024
  49. Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women. J Clin Endocrinol Metab. 2020 12 01; 105(12).
    View in: PubMed
    Score: 0.018
  50. Pet Ownership and Cardiovascular Health in the US General Population. Am J Cardiol. 2020 04 15; 125(8):1158-1161.
    View in: PubMed
    Score: 0.017
  51. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials. Cardiovasc Drugs Ther. 2016 Apr; 30(2):189-98.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.